Maya Latimer
Overview
Explore the profile of Maya Latimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiong I, Wall M, Bajel A, Kalro A, Fleming S, Roberts A, et al.
Blood Cancer J
. 2024 Mar;
14(1):54.
PMID: 38531863
Despite an increasing desire to use historical cohorts as "synthetic" controls for new drug evaluation, limited data exist regarding the comparability of real-world outcomes to those in clinical trials. Governmental...
2.
Campbell A, Teh B, Mulligan S, Ross D, Weinkove R, Gilroy N, et al.
Intern Med J
. 2023 Dec;
54(2):328-336.
PMID: 38146232
Despite widespread vaccination rates, we are living with high transmission rates of SARS-CoV-2. Although overall hospitalisation rates are falling, the risk of serious infection remains high for patients who are...
3.
Loo S, Roberts A, Anstee N, Kennedy G, He S, Schwarer A, et al.
Blood
. 2023 Aug;
142(23):1960-1971.
PMID: 37647654
Sorafenib maintenance improves outcomes after hematopoietic cell transplant (HCT) for patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) acute myeloid leukemia (AML). Although promising outcomes have been reported for...
4.
Lim K, Di Ciaccio P, Polizzotto M, Milliken S, Cochrane T, Goh Z, et al.
Br J Haematol
. 2023 Mar;
201(5):865-873.
PMID: 36866733
Antiretroviral therapy (ART) has improved outcomes for human immunodeficiency virus-associated non-Hodgkin lymphoma (HIV-NHL). This is an analysis of 44 patients with HIV with Burkitt lymphoma (HIV-BL) and diffuse large B-cell...
5.
Goh Z, Latimer M, Lewis K, Cheah C, Di Ciaccio P, Cushion T, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Feb;
23(5):370-378.
PMID: 36804727
Background: There is no standard front-line therapy for older patients with classical Hodgkin lymphoma (cHL). We analyzed the clinical presentation and front-line management of older Australian patients with cHL and...
6.
Perram J, Purtill D, Bajel A, Butler J, OBrien T, Teh B, et al.
Intern Med J
. 2022 Nov;
53(1):119-125.
PMID: 36371767
Patients with post-haemopoietic stem cell transplant or chimeric antigen receptor T -cell (CAR-T) therapy face a significant risk of morbidity and mortality from coronavirus disease 2019 because of their immunosuppressed...
7.
Hapgood G, Latimer M, Lee S, Kuss B, Lade S, Tobin J, et al.
Intern Med J
. 2021 Oct;
52(10):1806-1817.
PMID: 34668281
Peripheral T-cell lymphomas (PTCL) represent a heterogeneous disease group accounting for 10% of non-Hodgkin lymphomas. PTCL patients have typically poorer outcomes compared with aggressive B-cell lymphomas. However, such outcomes are...
8.
Wight J, Hamad N, Campbell B, Ku M, Lee K, Rose H, et al.
Intern Med J
. 2021 Sep;
52(9):1609-1623.
PMID: 34532916
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype, accounting for 30-40% of lymphoma diagnoses. Although aggressive, cure is achievable in approximately 60% of cases with primary chemoimmunotherapy,...
9.
Cochrane T, Campbell B, Gangatharan S, Latimer M, Khor R, Christie D, et al.
Intern Med J
. 2021 Sep;
51(12):2119-2128.
PMID: 34505342
The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a...
10.
McCaughan G, Di Ciaccio P, Ananda-Rajah M, Gilroy N, MacIntyre R, Teh B, et al.
Intern Med J
. 2021 May;
51(5):763-768.
PMID: 34047035
Australia and New Zealand have achieved excellent community control of COVID-19 infection. In light of the imminent COVID-19 vaccination roll out in both countries, representatives from the Haematology Society of...